Invitation to participate in the 3
rd
EU HCV Policy
Virtual Summit on the elimination of Hepatitis C
in Europe Securing Wider EU Commitment to the
elimination of HCV 24 March 2021 2pm – 6pm
Dear Mr Nielsen
On behalf of the Hepatitis B and C Public Policy Association we have the pleasure to
invite you to participate in the Association’s upcoming
European Policy
Summit
dedicated to the elimination of the hepatitis C virus (HCV) in Europe entitled
Securing Wider EU Commitment to the Elimination of HCV.
As a champion of the
healthcare sector and given your commitment to shaping the policy agenda to
improve patients’ lives, we would be delighted if you could join.
The Summit,
which is organised in partnership with leading patient and professional associations,
will be held virtually on the
24th March 2021, between 2pm and 6pm.
Despite the progress that has been made in recent years, HCV remains a major
public health problem in Europe. In the European Union (EU) more people die each
year from HCV than from HIV/AIDS. The latest data for the WHO European Region
shows an estimated 15 million people have hepatitis C, which equates to 2.0% of all
adults. When the elimination strategy was published in May 2016, the World Health
Organization (WHO) estimated that more than 7 million lives would be saved
worldwide by 2030, if targets were achieved. However, according to recent European
Centre for Disease Prevention and Control (ECDC) findings, only a few European
countries have met the 2020 target of the European Action Plan in diagnosing 50% of
people with chronic hepatitis B or C.
In the context of strained healthcare systems and shifting priorities, largely as a result
of the COVID-19 crisis, it is essential to ensure that the importance of efforts to